cell lymphoma
Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy
... V enereologica doi: 10.2340/00015555-2543 This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta Subcutaneous panniculitis-like T-cell lymphoma (SPT- CL) is a rare condition ...
8
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
... 8 Introduction Mantle cell lymphoma (MCL) accounts for 3% to 6% of all cases of non-Hodgkin lymphoma (NHL). Considered incurable, MCL is characterized by a high risk of relapse responsible for a ...
49
Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma
... inhibitor (PI) bortezomib (BTZ), also known as Velcade, was, in 2003 and 2006, the first Food and Drug Administration (FDA)-approved PI for the treatment of two haematological malignancies: multiple myeloma (MM) and ...
32
BMP7 Expression Correlates with Secondary Drug Resistance in Mantle Cell Lymphoma
... in lymphoma cells and in normal germinal center B-cells ...B-cell lymphoma cells can escape BMP-induced inhibition of cell growth suggesting an autocrine growth regulation and that malignant ...
10
Gene expression-based risk score in diffuse large B-cell lymphoma.
... B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and displays heterogeneous clinical and molecular ...B cell–like (ABC) molecular subgroups of patients as well as in ...
12
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.: MRD after immunochemotherapy in mantle-cell lymphoma
... Mantle cell lymphoma (MCL) is characterized by a mostly advanced stage of disease at diagnosis and an aggressive clinical course with a short median overall survival (OS) of 3-4 years after standard ...stem ...
32
Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.
... B cell lymphoma has been reported for several patients not included in these cohort studies - thus further highlighting the risk of B cell lymphoma in patients with APDS1 or APDS2 (Table ...B ...
17
CD4 T-Helper Responses to the Anaplastic Lymphoma Kinase (ALK) Protein in Patients with ALK-Positive Anaplastic Large-Cell Lymphoma
... 1 Nuffield Department of Clinical Laboratory Sciences, Leukemia Research Fund Immunodiagnostics Unit, John Radcliffe Hospital, and 2 Transplant Immunology, Oxford Transplant Center, Churchill Hospital, Oxford, United ...
5
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
... T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets Reliable information regarding the current prevalence of peripheral T-cell ...
4
Description of Two Cases of Anaplastic Large Cell Lymphoma Associated with a Breast Implant
... a part of this sample demonstrated no infectious sign. The pathologic evaluation of the second part of this sample identi- fied atypical cells (Figure 5(a)) and a positivity for CD30 (Fig- ure 5(b)). Immunohistochemical ...
7
Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii
... Burkitt lymphoma in Tanzania, in preventing the development of B-cell lymphoma in mice and in inducing apoptosis of malignant B-cells in patients with chronic lymphocytic ...
3
Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma
... cells lymphomas. Indeed, an increased expression of both CD86 and CD80 in response to TLR9 stimulation was shown in chronic lymphocytic leukemia, but not in response to TLR7 stimulations [21]. Follicular lymphoma ...
11
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.: IDH2 mutations in AITL
... data Lymphoma and leukemia DNA samples from frozen tissue were provided by a multicentric T-cell lymphoma consortium (Tenomic) and the University of Hong Kong ...(UNMC) Lymphoma Tumor Bank [ ...
6
Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.
... Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin’s lymphoma (NHL), representing about 6% of NHL ...and cell cycle deregulation ...
5
Long non-coding RNAs as molecular signatures for canine B-Cell lymphoma characterization
... B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in ...in lymphoma pathogenesis and pinpointed a ...
12
CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma
... B-cell lymphoma; DLBCL(t): diffuse large B-cell lymphoma trans- formed; TCR: T-cell rich B-cell lymphoma; # subtyped according to expression of CD10, BCL-6 and MUM1; GCB: ...
9
Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly.
... A diagnosis of PTCL, NOS was rendered (splenectomy, see below). Altogether, including minimal involvement of the liver and bone marrow, clinical staging was stage IVB, inter- national prognostic index (IPI) score was 5, ...
7
Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma
... B-cell lymphoma Diffuse large B-cell lymphoma (DLBCL), representing 40% of non-Hodgkin lymphoma (NHL), is heterogeneous with respect to morphology, clinical features and immunopheno- ...
12
Role of ETS1 in the transcriptional network of diffuse large B cell lymphoma of the activated B cell-like type
... B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell ...
17
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.: Molecular Signature of Hepatosplenic T-cell Lymphoma
... T-cell lymphoma (HSTL), originally described as hepatosplenic γδ T cell lymphoma, is a rare lymphoma entity with peculiar clinical presentation - hepatosplenomegaly without significant ...
41